The biotech industry is growing rapidly but facing many new challenges, from revised PTO guidelines to the possibilities of licensing and patent pooling. Tabitha Parker asks senior in-house counsel how they are coping with change
Monster.com, Unilever and Lucent have all recently suffered from the alleged theft of trade secrets. With more online companies and a greater dependence on electronic methods of storage and transfer of information, corporate espionage is set to become a major threat, reports Tabitha Parker
The UK domain name registry, Nominet, is amending its dispute resolution process. Sarah Harrington examines the proposals and reveals why they may cause concern to brand owners
Franchisors who try to stop franchisees from selling outside their allocated territories in the EU may fall foul of competition legislation. Mark Abell analyzes how EU law is developing to cope with the internet
Trade marks are particularly vulnerable to becoming non-distinctive in Russia. Vitaly Kaliatin discusses four scenarios where this risk occurs and looks at how it can be avoided
James G Conley and John J Szobocsan ask how IP owners can achieve sustainable competitive advantage through protected differentiation. Or, in other words, why am I in this long line to buy a Snow White video – a film first released in 1937?
In a landmark case, a UK court has ruled that oil company BP can stop rivals from using its distinctive colour green on their service stations. Ian Wood, Nicola Boxall and Mary Bagnall examine the decision
Cathryn Warburton explains how and why Customs notices are an essential part of anti-counterfeiting in New Zealand, and answers the most common questions about border protection measures
The Advocate General’s Opinion in the Davidoff and Levi’s case was welcomed by both brand owners and parallel importers. David Rose analyzes the Opinion and suggests that brand owners have slightly more to be pleased about
In the spotlight: Woody Ritchey, Chief Executive Officer, Delphion
Hiroshi Sheraton, McDermott, Will & Emery, London
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
ICYMI: our PTAB November round-up: filing slumps; tribal immunity briefs filed; Oil States and SAS argued; Aqua Pro… https://t.co/SXYidoVKEK
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International